"10.1371_journal.pone.0073290","plos one","2013-09-12T00:00:00Z","Esther M Opmeer; Rudie Kortekaas; Marie-José van Tol; Nic J A van der Wee; Saskia Woudstra; Mark A van Buchem; Brenda W Penninx; Dick J Veltman; André Aleman","Neuroimaging Center, Department of Neuroscience, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands; Department of Psychiatry, Leiden University Medical Center, Leiden University, Leiden, The Netherlands; Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands; Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands; Department of Medical Genomics, VU University Medical Center, Amsterdam, The Netherlands; Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Psychology, University of Groningen, Groningen, The Netherlands","Conceived and designed the experiments: DV NvdW MvB BP AA. Performed the experiments: EO MJvT SW. Analyzed the data: EO MJvT. Analyzed the data, provided suggestions: RK DV NvdW AA. Wrote the manuscript: EO. Wrote the manuscript, provided contributions: RK MJvT NvdW SW MvB BP DV AA.","Esther Opmeer, Marie-José van Tol, Rudie Kortekaas, Saskia Woudstra, Mark van Buchem, Brenda Penninx and Dick Veltman declare no conflict of interest. Nic van der Wee received speaking fees from Eli Lilly and Wyeth; and served on advisory panels of Eli Lilly, Pfizer, Wyeth and Servier. André Aleman received an investigator-initiated unrestricted research grant from Bristol-Myers Squibb and speakers bureau honoraria from AstraZeneca, Bristol-Myers Squibb and GlaxoSmithKline. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.",11,1,0,"2013","09","Esther M Opmeer","EMO",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
